BCL2 and acute myeloid leukemia: In addition, TG02 was shown to synergize with the BCL-2 antagonist venetoclax (ABT-199), which sensitizes to the MCL-1-inhibitory NOXA-BH3 peptide, to induce apoptosis in AML cells.